Dogs

Dog Atopic Dermatitis Long-term Management

Canine atopic dermatitis causes chronic itching, skin damage and secondary infections. Effective long-term management using targeted therapies significantly improves quality of life.

Key Facts

Atopic dermatitis affects an estimated 10-15% of dogs and is the second most common skin disease
Genetic predisposition combined with environmental allergen exposure drives the condition
Constant scratching, licking and chewing causes skin damage, secondary infections and hair loss
Newer targeted therapies including oclacitinib (Apoquel) and lokivetmab (Cytopoint) provide effective control
Allergen-specific immunotherapy offers the possibility of long-term tolerance in selected dogs

Welfare Considerations

Chronic pruritus (itching) causes significant suffering that is often underestimated by owners who have normalized their dog's scratching. Sleep disruption, skin pain from self-trauma and restricted activity are all welfare impacts. Modern targeted therapies provide safe and effective itch control with fewer side effects than steroids, representing a major welfare advance for affected dogs.

What You Can Do

Seek veterinary dermatology assessment for dogs with chronic itching, licking or skin infections
Request targeted anti-itch therapy rather than relying solely on steroids for long-term management
Investigate environmental allergens and institute allergen avoidance measures where possible
Consider allergen-specific immunotherapy for long-term management reducing medication dependence
Maintain skin barrier health with regular appropriate bathing and moisturizing treatments